Authors
Loading...
In vitro study demonstrates enhanced gene transfection in leukemia cells using transferrin-targeted cyclodextrin nanoparticles, highlighting potential for systemic cancer therapy.
Bellocq et al. (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: